- AU$508.21m
- AU$444.20m
- AU$336.37m
- 74
- 74
- 60
- 79
Annual income statement for Lycopodium, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 159 | 229 | 326 | 348 | 336 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 141 | 192 | 265 | 281 | 281 |
| Operating Profit | 17.6 | 37.1 | 60.4 | 67.4 | 55.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 21.5 | 38.9 | 63.3 | 69.7 | 60.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 14.1 | 26.9 | 45.6 | 50.9 | 42.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 14.2 | 27.2 | 46.8 | 50.7 | 42.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 14.2 | 27.2 | 46.8 | 50.7 | 42.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.355 | 0.684 | 1.18 | 1.28 | 1.06 |
| Dividends per Share |